Across three different experimental rodent models of diabetic and non-diabetic kidney disease we observed that EP4 inhibition attenuated albuminuria or proteinuria, independent risk markers of renal decline26 and mortality27. This evidence concerns the gene PTGER4 and kidney disorder.